Search Results - "Lim-Harashima Jeraldine"

Fragile X syndrome carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines by Johansen Taber, Katherine, Lim‐Harashima, Jeraldine, Naemi, Harris, Goldberg, Jim

“…Background Fragile X syndrome (FXS) is the most common inherited form of intellectual disability. Many providers offer preconception or prenatal FXS carrier…”
Get full text

Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study by Pappas, Dimitrios A., Brittle, Christine, Mossell, James E., Withers, Johanna B., Lim-Harashima, Jeraldine, Kremer, Joel M.

“…Tumor necrosis factor inhibitor (TNFi) therapies are often the first biologic therapy used to treat rheumatoid arthritis (RA) patients. However, a substantial…”
Get full text

Correction: Sequencing as a first-line methodology for cystic fibrosis carrier screening by Beauchamp, Kyle A., Taber, Katherine A. Johansen, Grauman, Peter V., Spurka, Lindsay, Lim-Harashima, Jeraldine, Svenson, Ashley, Goldberg, James D., Muzzey, Dale

“…The original version of this Article contained an error in Figure 3. Specifically, the result “3 (67%) TOP” should read “2 (67%) TOP.” This has now been…”
Get full text

Fragile X carrier screening accompanied by genetic consultation has clinical utility in populations beyond those recommended by guidelines by Taber, Katie Johansen, Lim-Harashima, Jeraldine, Naemi, Harris, Goldberg, Jim

Get full text

Sequencing-Based Carrier Screening for Cystic Fibrosis: Ready for Prime Time? [16O] by Beauchamp, Kyle, Grauman, Peter, Spurka, Lindsay, Lim-Harashima, Jeraldine, Muzzey, Dale

“…INTRODUCTION:Medical-society guidelines recommend offering carrier screening for cystic fibrosis (CF) to all women who are considering pregnancy or already…”
Get full text

Sequencing as a first-line methodology for cystic fibrosis carrier screening by Beauchamp, Kyle A., Johansen Taber, Katherine A., Grauman, Peter V., Spurka, Lindsay, Lim-Harashima, Jeraldine, Svenson, Ashley, Goldberg, James D., Muzzey, Dale

“…Purpose Medical society guidelines recommend offering genotyping-based cystic fibrosis (CF) carrier screening to pregnant women or women considering pregnancy…”
Get full text

Guided therapy selection in rheumatoid arthritis using a molecular signature response classifier: an assessment of budget impact and clinical utility by Arnell, Christopher, Bergman, Martin, Basu, Dhiman, Kenney, James T, Withers, Johanna B, Logan, Jennifer, Harashima, Jeraldine Lim, Connolly-Strong, Erin

“…Patients with moderate to severe rheumatoid arthritis (RA) can be treated with a range of targeted therapies following inadequate response to conventional…”
Get full text

Sequencing as a first-line methodology for cystic fibrosiscarrier screening by Beauchamp, Kyle A, Johansen Taber Katherine A, Grauman, Peter V, Spurka Lindsay, Lim-Harashima Jeraldine, Svenson, Ashley, Goldberg, James D, Muzzey Dale

“…PurposeMedical society guidelines recommend offering genotyping-based cystic fibrosis (CF) carrier screening to pregnant women or women considering pregnancy…”
Get full text